Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 11/20 | 0.65 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3913720 | 0.85 | MTNR1A (0.68) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL13626837 | 0.84 | MTNR1A (0.49) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL13626146 | 0.83 | MTNR1A (0.48) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL13612551 | 0.80 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL8526049 | 0.79 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961221 | 0.78 | MTNR1A (0.80) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL4321154 | 0.78 | MTNR1A (0.59) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL4317050 | 0.78 | MTNR1A (0.59) | MTNR1AMTNR1BNQO2RAB9ASMN1; SMN2 | |
| SCHEMBL8961115 | 0.78 | MTNR1A (0.80) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961126 | 0.78 | MTNR1A (0.84) | MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281154-A1 | Ophthalmic Compositions for Treating Ocular Hypertension | MERCK SHARP & DOHME CORP. | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281154-A1 | Ophthalmic Compositions for Treating Ocular Hypertension | KCNN1, KCNN3, KCNN2 | MTNR1A 357/4885MTNR1B 345/4885NQO2 836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.